Oral Supplementation With a Bovine Thymus Extract Reduces Neuronal Excitability in Aging Mice.
Thymus nuclear fraction supplementation in aging mice showed increased GABAergic protein expression and reduced neuronal excitability, but the implications for human health are unclear.
Where it sits
this study against the rest of the thymalin/thimulin corpusSummary and findings
This study investigated the effects of oral supplementation with a bovine thymus extract (thymus nuclear fraction-TNF) on neuronal excitability in aging mice over 14 weeks. The study measured GABAergic protein expression and cortical neuronal activity. Findings indicated increased expression of GAD65, GAD67, and GABA<sub>A</sub> receptor subunits, alongside reduced neuronal excitability.
Abstract
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS). Many aspects of GABAergic neurotransmission, including the densities of GABAergic neurons, the synthesis of GABA and its interaction with the respective receptors, are believed to be altered during aging, contributing to increased neuronal excitability seen in multiple neurodegenerative conditions, such as dementias, Alzheimer's disease, and traumatic brain injury (TBI). Oral administration of a nuclear fraction extract of the bovine thymus gland (thymus nuclear fraction-TNF) to rats was recently reported to improve their functional recovery from controlled cortical impact (CCI)-an animal model of TBI. Given that individual thymic peptides and mixed thymus fractions were also found to have broad neuroprotective effects and anti-neuroinflammatory activity, we sought to investigate the impact of TNF on GABAergic neurotransmission in the aging mouse brain. Using biochemical investigation, electrophysiological recordings, obtained using electroencephalography (EEG), and power spectral density analysis, we evaluated GABAergic protein expression and cortical neuronal activity in aged control mice and in mice supplemented with a low dose (LD) or a high dose of TNF for 14 weeks. We uncovered increased expression of two isoforms of glutamic acid decarboxylase, GAD65 and GAD67, and increased levels of β2/β3 subunits of GABA<sub>A</sub> receptor in the brains of TNF-supplemented mice compared to the control group, suggesting possible enhancement of inhibitory neurotransmission. Decreased neuronal excitability, evidenced by reduced EEG amplitudes, power spectral densities, and peak amplitudes of high-frequency cortical oscillations, further confirmed a dose-dependent attenuation of neuronal excitability by TNF. Our results suggest that TNF supplementation may have the potential to mitigate age-related alterations in GABAergic neurotransmission, thereby modulating neuronal excitability.